De Groot Eleanor 4
4 · ZIOPHARM ONCOLOGY INC · Filed Mar 8, 2021
Insider Transaction Report
Form 4
De Groot Eleanor
EVP, GM Cell Therapy
Transactions
- Award
Common Stock
2021-03-04+50,825→ 257,238 total - Award
Employee Stock Option (right to buy)
2021-03-04+381,188→ 381,188 totalExercise: $4.31Exp: 2031-03-04→ Common Stock (381,188 underlying)
Footnotes (2)
- [F1]12,707 shares shall vest on 12/31/2021 and 12,706 shares shall vest on each of 12/31/2022, 12/31/2023 and 12/31/2024.
- [F2]1/16th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2020.